Considering the distinct anatomy and increased systemic CRP levels suggesting a more pro-inflammatory profile of PAD relative to CAD, it is crucial to investigate the impact of inflammation on PAD-related outcomes independently (15). This evidence concerns the gene CRP and peripheral arterial disease.